303 related articles for article (PubMed ID: 34964688)
1. Uterine Fibroids: Hiding in Plain Sight.
Stewart EA; Nowak RA
Physiology (Bethesda); 2022 Jan; 37(1):16-27. PubMed ID: 34964688
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
3. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
4. MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
Mäkinen N; Vahteristo P; Kämpjärvi K; Arola J; Bützow R; Aaltonen LA
Eur J Hum Genet; 2013 Nov; 21(11):1300-3. PubMed ID: 23443020
[TBL] [Abstract][Full Text] [Related]
5. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of uterine fibroids: current trends and future strategies.
Ahmad A; Kumar M; Bhoi NR; Badruddeen ; Akhtar J; Khan MI; Ajmal M; Ahmad M
J Basic Clin Physiol Pharmacol; 2023 May; 34(3):291-310. PubMed ID: 36989026
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Analysis Identifies Tenascin-C Expression Is Upregulated in Uterine Fibroids.
Jamaluddin MFB; Nagendra PB; Nahar P; Oldmeadow C; Tanwar PS
Reprod Sci; 2019 Apr; 26(4):476-486. PubMed ID: 29730954
[TBL] [Abstract][Full Text] [Related]
8. Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.
Segars JH; Parrott EC; Nagel JD; Guo XC; Gao X; Birnbaum LS; Pinn VW; Dixon D
Hum Reprod Update; 2014; 20(3):309-33. PubMed ID: 24401287
[TBL] [Abstract][Full Text] [Related]
9. Novel MED12 gene somatic mutations in women from the Southern United States with symptomatic uterine fibroids.
Halder SK; Laknaur A; Miller J; Layman LC; Diamond M; Al-Hendy A
Mol Genet Genomics; 2015 Apr; 290(2):505-11. PubMed ID: 25325994
[TBL] [Abstract][Full Text] [Related]
10. Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors.
Nowak RA
Environ Health Perspect; 2000 Oct; 108 Suppl 5():849-53. PubMed ID: 11035994
[TBL] [Abstract][Full Text] [Related]
11. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
13. Management of leiomyomas in perimenopausal women.
Ciarmela P; Ciavattini A; Giannubilo SR; Lamanna P; Fiorini R; Tranquilli AL; Christman GM; Castellucci M
Maturitas; 2014 Jul; 78(3):168-73. PubMed ID: 24835002
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic management of uterine fibroid tumors: updated French guidelines.
Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
[TBL] [Abstract][Full Text] [Related]
15. Uterine fibroid embolization: a viable alternative to hysterectomy.
Bradley LD
Am J Obstet Gynecol; 2009 Aug; 201(2):127-35. PubMed ID: 19646564
[TBL] [Abstract][Full Text] [Related]
16. Analysis of
Lee M; Cheon K; Chae B; Hwang H; Kim HK; Chung YJ; Song JY; Cho HH; Kim JH; Kim MR
Int J Med Sci; 2018; 15(2):124-128. PubMed ID: 29333096
[TBL] [Abstract][Full Text] [Related]
17. Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma.
Bhat AS; Singh NA; Rymbai E; Birendra S; Jayaram S; Selvaraj D
Reprod Sci; 2023 May; 30(5):1383-1398. PubMed ID: 35969363
[TBL] [Abstract][Full Text] [Related]
18. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
19. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan catabolism is dysregulated in leiomyomas.
Chuang TD; Quintanilla D; Boos D; Khorram O
Fertil Steril; 2021 Oct; 116(4):1160-1171. PubMed ID: 34116832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]